Siglec‐15 promotes the migration of liver cancer cells by repressing lysosomal degradation of CD44
出版年份 2021 全文链接
标题
Siglec‐15 promotes the migration of liver cancer cells by repressing lysosomal degradation of CD44
作者
关键词
-
出版物
FEBS LETTERS
Volume 595, Issue 17, Pages 2290-2302
出版商
Wiley
发表日期
2021-07-30
DOI
10.1002/1873-3468.14169
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- ST6GAL2 Downregulation Inhibits Cell Adhesion and Invasion and is Associated with Improved Patient Survival in Breast Cancer
- (2020) Junchi Cheng et al. OncoTargets and Therapy
- Targeting glycosylated antigens on cancer cells using siglec‐7/9‐based CAR T‐cells
- (2020) Sara Meril et al. MOLECULAR CARCINOGENESIS
- Siglec-15 as an emerging target for next-generation cancer immunotherapy
- (2020) Jingwei Sun et al. CLINICAL CANCER RESEARCH
- A versatile soluble siglec scaffold for sensitive and quantitative detection of glycan ligands
- (2020) Emily Rodrigues et al. Nature Communications
- Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
- (2019) Jun Wang et al. NATURE MEDICINE
- Sialic acid–binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses
- (2019) Heinz Läubli et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer
- (2019) Lichun Ma et al. CANCER CELL
- Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
- (2019) Shuang Qin et al. Molecular Cancer
- Immune checkpoint therapy in liver cancer
- (2018) Feng Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The biology and role of CD44 in cancer progression: therapeutic implications
- (2018) Chen Chen et al. Journal of Hematology & Oncology
- Cell-based glycan arrays for probing glycan–glycan binding protein interactions
- (2018) Jennie Grace Briard et al. Nature Communications
- CD44 Orchestrates Metastatic Teamwork
- (2018) Christine L. Chaffer et al. DEVELOPMENTAL CELL
- DNMT3L facilitates DNA methylation partly by maintaining DNMT3A stability in mouse embryonic stem cells
- (2018) Nicolas Veland et al. NUCLEIC ACIDS RESEARCH
- Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models
- (2018) Xia Liu et al. Cancer Discovery
- Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions
- (2018) Joyce Lübbers et al. Frontiers in Immunology
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Adaptive Immune Resistance: How Cancer Protects from Immune Attack
- (2015) A. Ribas Cancer Discovery
- CD22 and Siglec-G regulate inhibition of B-cell signaling by sialic acid ligand binding and control B-cell tolerance
- (2014) L. Nitschke GLYCOBIOLOGY
- Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells
- (2013) Y. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF- secretion from monocytes/macrophages through the DAP12-Syk pathway
- (2012) R. Takamiya et al. GLYCOBIOLOGY
- Siglec-15, a member of the sialic acid-binding lectin, is a novel regulator for osteoclast differentiation
- (2011) Yoshiharu Hiruma et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Toward a stem cell gene therapy for breast cancer
- (2009) Z. Li et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started